NCT05110118View on ClinicalTrials.gov

Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

January 13, 2021

Study Completion Date

January 13, 2021

Conditions

Metastatic Colorectal CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Recurrent

Interventions

DRUG

LY01008

Single intravenous injection

DRUG

Avastin

Single intravenous injection

Trial Locations (1)

Unknown

The Second Hospital of Anhui Medical University, Hefei

All Listed Sponsors

lead

Shandong Boan Biotechnology Co., Ltd

INDUSTRY

NCT05110118 - Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects | Biotech Hunter | Biotech Hunter